Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties

Christian P. Larsen, Thomas C. Pearson, Andrew B. Adams, Paul Tso, Nozomu Shirasugi, Elizabeth Strobert, Dan Anderson, Shannon Cowan, Karen Price, Joseph Naemura, John Emswiler, Jo Anne Greene, Lori Ann Turk, Jurgen Bajorath, Robert Townsend, David Hagerty, Peter S. Linsley, Robert J. Peach

Research output: Contribution to journal › Article › peer-review